This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignee: Karus Therapeutics Limited. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hampshire, GB (2013 - 2015)
- Southampton, GA (2015)
- Abingdon, GB (2017)
- Oxfordshire, GB (2018 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: Innovations of Thomas James Hill
Introduction
Thomas James Hill is a notable inventor based in Hampshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific kinases. With a total of six patents to his name, Hill's work is recognized for its potential therapeutic applications.
Latest Patents
Among his latest patents, Hill has developed tricyclic heterocyclic compounds that act as phosphoinositide 3-kinase inhibitors. These compounds, described by specific chemical formulas, have shown surprising efficacy in inhibiting PI3K-p110δ. This discovery holds promise for therapeutic use, particularly in treating various diseases.
Career Highlights
Hill is currently associated with Karus Therapeutics Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on creating compounds that can lead to advancements in medical treatments. His expertise in chemistry and pharmacology has positioned him as a key figure in his field.
Collaborations
Throughout his career, Hill has collaborated with notable professionals such as Stephen Joseph Shuttleworth and Franck Alexandre Silva. These partnerships have contributed to the development of his innovative compounds and have enhanced the research capabilities of his team.
Conclusion
Thomas James Hill's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile